Friday 1st April was the final day of the Fordham conference. This short report summarises one of the more interesting patent-focused sessions which dealt with second medical use issues.
Brian…
As a foreign spectator of the litigation between Actavis and Eli Lilly (Alimta®) before the English Patents Court (the Hon. Mr. Justice Arnold), this author was fascinated by the ease with which the…
For 2016, the Fordham Conference has returned to its home on the Upper West side of Manhattan. In the meantime, the Institute has been rebuilt and the shabby-chic has been replaced with a state of…
There was a time where appeal before the EPO could be used to revisit anything that went wrong or was omitted in opposition proceedings.
Since 2003, when the Rules of Procedure of the Boards of…
For nearly a decade the Latvian regulators have struggled with determining the future perspective for resolving intellectual property related disputes before the Patent Office of the Republic of…
The Spanish Patents and Trademarks Office ("SPTO") has submitted the draft of the Implementing Regulations of the new Spanish Patents Act, which is due to come into force on 1 April 2017, for public…
A patent application was properly denied on the basis that it covered the abstract idea of rules for playing a wagering game and used conventional steps of shuffling and dealing a standard deck of…
The U.K. Patents Court has held Warner-Lambert's second medical use patent regarding the use of pregabalin for the treatment of pain invalid on the ground of insufficiency. Even if the patent were…
Although patentability is generally regarded as a question of law per se, the actual technical disclosure of a prior art example was seen as a question of fact and therefore a matter for the first-…
Europe is preparing for the launch of the new Unitary Patent and the Unified Patent Court (UPC). A provisional phase for the UPC is expected to start later this year, with a view to a full start of…
